Back to calendar
C4 Therapeutics, Inc. (CCCC) Earnings
CCCC reports earnings on Monday, November 2, 2026
earnings report
November 2, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.19
Actual EPS: $-0.18
EPS surprise: 20.49%
Company overview
Market Cap$414.6M
PriceUSD 3.37
EPS (TTM)-1.00
52-week high5.17
52-week low1.69
SectorHealth Technology
IndustryBiotechnology
Employees104